BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9419452)

  • 1. Induction of dendritic cells (DC) by Flt3 Ligand (FL) promotes the generation of tumor-specific immune responses in vivo.
    Lynch DH
    Crit Rev Immunol; 1998; 18(1-2):99-107. PubMed ID: 9419452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flt3 ligand induces tumor regression and antitumor immune responses in vivo.
    Lynch DH; Andreasen A; Maraskovsky E; Whitmore J; Miller RE; Schuh JC
    Nat Med; 1997 Jun; 3(6):625-31. PubMed ID: 9176488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential induction of Th1 responses by functionally mature hepatic (CD8alpha- and CD8alpha+) dendritic cells: association with conversion from liver transplant tolerance to acute rejection.
    Morelli AE; O'Connell PJ; Khanna A; Logar AJ; Lu L; Thomson AW
    Transplantation; 2000 Jun; 69(12):2647-57. PubMed ID: 10910289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
    Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
    J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand.
    Daro E; Pulendran B; Brasel K; Teepe M; Pettit D; Lynch DH; Vremec D; Robb L; Shortman K; McKenna HJ; Maliszewski CR; Maraskovsky E
    J Immunol; 2000 Jul; 165(1):49-58. PubMed ID: 10861034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells in models of tumor immunity. Role of Flt3 ligand.
    Maliszewski C
    Pathol Biol (Paris); 2001 Jul; 49(6):481-3. PubMed ID: 11484609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo.
    Ohm JE; Shurin MR; Esche C; Lotze MT; Carbone DP; Gabrilovich DI
    J Immunol; 1999 Sep; 163(6):3260-8. PubMed ID: 10477595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene gun-mediated skin transfection with FL gene suppresses the growth of murine fibrosarcoma.
    Abe A; Furumoto H; Yoshida K; Kato T; Saijo Y; Irahara M
    J Med Invest; 2011 Feb; 58(1-2):39-45. PubMed ID: 21372485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generating a T cell tumor-specific immune response in vivo: can flt3-ligand-generated dendritic cells tip the balance?
    McKenna HJ
    Cancer Immunol Immunother; 1999 Sep; 48(6):281-6. PubMed ID: 10473802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid neoplasm-related gene abnormalities differentially affect dendritic cell differentiation from murine hematopoietic stem/progenitor cells.
    Fujita J; Mizuki M; Otsuka M; Ezoe S; Tanaka H; Satoh Y; Fukushima K; Tokunaga M; Matsumura I; Kanakura Y
    Immunol Lett; 2011 Apr; 136(1):61-73. PubMed ID: 21237204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy.
    Berhanu A; Huang J; Alber SM; Watkins SC; Storkus WJ
    Cancer Res; 2006 May; 66(9):4895-903. PubMed ID: 16651446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant effect of a Flt3 ligand (FL) gene-transduced xenogeneic cell line in a murine colon cancer model.
    Kim EM; Sivanandham M; Stavropoulos CI; Wallack MK
    J Surg Res; 2002 Nov; 108(1):148-56. PubMed ID: 12443727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLT3-ligand administration inhibits liver metastases: role of NK cells.
    PĂ©ron JM; Esche C; Subbotin VM; Maliszewski C; Lotze MT; Shurin MR
    J Immunol; 1998 Dec; 161(11):6164-70. PubMed ID: 9834102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF.
    Daro E; Butz E; Smith J; Teepe M; Maliszewski CR; McKenna HJ
    Cytokine; 2002 Feb; 17(3):119-30. PubMed ID: 11895330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo.
    Pulendran B; Banchereau J; Burkeholder S; Kraus E; Guinet E; Chalouni C; Caron D; Maliszewski C; Davoust J; Fay J; Palucka K
    J Immunol; 2000 Jul; 165(1):566-72. PubMed ID: 10861097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FLT3 ligand induces the generation of functionally active dendritic cells in mice.
    Shurin MR; Pandharipande PP; Zorina TD; Haluszczak C; Subbotin VM; Hunter O; Brumfield A; Storkus WJ; Maraskovsky E; Lotze MT
    Cell Immunol; 1997 Aug; 179(2):174-84. PubMed ID: 9268501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties.
    Miller G; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP
    J Immunol; 2003 Apr; 170(7):3554-64. PubMed ID: 12646617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand.
    Hung CF; Hsu KF; Cheng WF; Chai CY; He L; Ling M; Wu TC
    Cancer Res; 2001 Feb; 61(3):1080-8. PubMed ID: 11221836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12 and Flt3 ligand differentially promote dendropoiesis in vivo.
    Esche C; Cai Q; Peron JM; Hunter O; Subbotin VM; Lotze MT; Shurin MR
    Eur J Immunol; 2000 Sep; 30(9):2565-75. PubMed ID: 11009090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo administration of flt3 ligand markedly stimulates generation of dendritic cell progenitors from mouse liver.
    Drakes ML; Lu L; Subbotin VM; Thomson AW
    J Immunol; 1997 Nov; 159(9):4268-78. PubMed ID: 9379022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.